Pain affects the lives of millions of Americans every day and improving pain care and the lives of patients with pain is a public health imperative.
Eli Lilly reports tirzepatide MASH success during Q4 earnings
The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the